Wealth Intelligence LLC Makes New $5.68 Million Investment in Danaher Corporation $DHR

Wealth Intelligence LLC acquired a new position in Danaher Corporation (NYSE:DHR) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 25,620 shares of the conglomerate’s stock, valued at approximately $5,676,000. Danaher accounts for approximately 2.5% of Wealth Intelligence LLC’s portfolio, making the stock its 9th largest holding.

Other hedge funds also recently bought and sold shares of the company. Banque Pictet & Cie SA grew its stake in shares of Danaher by 23.4% during the 3rd quarter. Banque Pictet & Cie SA now owns 145,326 shares of the conglomerate’s stock valued at $32,197,000 after purchasing an additional 27,534 shares during the period. Cyndeo Wealth Partners LLC grew its position in Danaher by 271.4% during the third quarter. Cyndeo Wealth Partners LLC now owns 11,041 shares of the conglomerate’s stock valued at $2,446,000 after buying an additional 8,068 shares during the period. Hanson & Doremus Investment Management increased its holdings in Danaher by 5,414.7% during the third quarter. Hanson & Doremus Investment Management now owns 4,136 shares of the conglomerate’s stock valued at $916,000 after buying an additional 4,061 shares during the last quarter. Aspiriant LLC increased its holdings in Danaher by 113.4% during the third quarter. Aspiriant LLC now owns 9,021 shares of the conglomerate’s stock valued at $1,999,000 after buying an additional 4,794 shares during the last quarter. Finally, Holcombe Financial Inc. bought a new position in Danaher in the third quarter worth approximately $1,139,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR traded down $2.63 during mid-day trading on Friday, reaching $228.87. The stock had a trading volume of 3,516,366 shares, compared to its average volume of 4,667,069. The company has a market cap of $160.89 billion, a P/E ratio of 40.65, a price-to-earnings-growth ratio of 2.91 and a beta of 0.76. The business’s 50 day moving average price is $214.04 and its 200 day moving average price is $195.97. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The company’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.77 EPS. Research analysts expect that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is 28.42%.

Analyst Ratings Changes

DHR has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Royal Bank Of Canada lifted their target price on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Barclays boosted their price target on Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a report on Wednesday, October 7th. Evercore reissued an “outperform” rating and set a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Finally, TD Cowen upped their price target on Danaher from $236.00 to $255.00 and gave the stock a “buy” rating in a research report on Tuesday. Two analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $235.41.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.